George W. Merck

Recent headlines mentioning George W. Merck and Merck (MRK) — pulled from Finnhub + Google News. Click any headline to open the original source.

• 
  A Futuristic Synthesis Indeed

  SeekingAlpha· 19h ago

  A recent paper by Merck details the industrial synthesis of enlicitide. Just looking at the structure tells you that this must be a ferociously active molecule with huge commercial potential

• 
  FDA Drug Chief Tracey Hoeg Fired Days After After Marty Makary's Exit— Says Order Came From 'Way Above'

  Benzinga· 1d ago

  Tracey Beth Hoeg was fired as FDA drug division chief amid a broader Trump administration shake-up at the health department.

• 
  Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

  CNBC· 1d ago

  U.S. drugmaker Bristol Myers Squibb inked a partnership with a Chinese company that some say could mark the next wave of collaboration across continents.

• 
  Merck ASCO 2026 Data Sheds Light On Oncology Outlook And Valuation

  Yahoo· 2d ago

  Merck (NYSE:MRK) plans to present more than 100 oncology abstracts at the 2026 ASCO Annual Meeting. The company will share five year outcomes from pivotal trials of KEYTRUDA combinations in melanoma and triple negativ…

• 
  Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know

  Yahoo· 2d ago

  Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.

• 
  Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial

  Yahoo· 2d ago

  Veeva Systems (NYSE: VEEV) will showcase the future of agentic commercial in biopharma at Veeva Commercial Summit, May 19-20 in Boston. Leaders from argenx, Bayer, Boehringer Ingelheim, Genentech, Gilead, GSK, Merck, …

• 
  Matrix connects two new renewable projects to Spanish grid

  Yahoo· 2d ago

  The new solar farms boost Matrix’s Spanish portfolio, supporting grid reliability and long-term clean power supply.

• 
  Precigen: Full Commercial Validation And Room To Run

  SeekingAlpha· 2d ago

  Precigen's PAPZIMEOS wins early FDA approval with rapid insurer/physician uptake, a strong growth outlook, and improving EPS. Click to read more on PGEN stock.